Defining breakthrough invasive fungal infection–Position paper of the mycoses study group education and research consortium and the European Confederation of Medical Mycology-Reference-Cited by-同舟云学术

Defining breakthrough invasive fungal infection–Position paper of the mycoses study group education and research consortium and the European Confederation of Medical Mycology

Published:2019-07-19 Issue: Volume: Page:
ISSN:0933-7407
Container-title:Mycoses
language:en
Short-container-title:Mycoses

Author:

Cornely Oliver A.¹²³^ORCID,Hoenigl Martin⁴⁵^ORCID,Lass‐Flörl Cornelia⁶,Chen Sharon C. ‐A.⁷,Kontoyiannis Dimitrios P.⁸^ORCID,Morrissey C. Orla⁹,Thompson George R.¹⁰^ORCID,

Affiliation:

1. Cologne Excellence Cluster on Cellular Stress Responses in Aging‐Associated Diseases (CECAD) University of Cologne Cologne Germany

2. Department I of Internal Medicine ECMM Center of Excellence for Medical Mycology German Centre for Infection Research, Partner Site Bonn‐Cologne (DZIF) University of Cologne Cologne Germany

3. Clinical Trials Centre Cologne (ZKS Köln) University of Cologne Cologne Germany

4. Division of Infectious Diseases University of California San Diego San Diego CA USA

5. Division of Pulmonology and Section of Infectious Diseases Medical University of Graz Graz Austria

6. Division of Hygiene and Microbiology ECMM Excellence Center for Medical Mycology Medical University Innsbruck Innsbruck Austria

7. Centre for Infectious Diseases and Microbiology Laboratory Services ICPMR New South Wales Health Pathology Westmead Hospital Centre for Infectious Diseases and Microbiology Sydney Medical School The University of Sydney Sydney NSW Australia

8. Department of Infectious Diseases, Infection Control, and Employee Health University of Texas M. D. Anderson Cancer Center Houston TX USA

9. Infectious Diseases Alfred Health and Monash University Melbourne VIC Australia

10. Departments of Medical Microbiology and Immunology and Internal Medicine Division of Infectious Diseases UC‐Davis Medical Center Sacramento CA USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

Infectious Diseases,Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/myc.12960

Reference182 articles.

1. Breakthrough invasive mold infections in the hematology patient: current concepts and future directions;Lionakis MS;Clin Infect Dis,2018

2. Breakthrough fungal infections in leukemia patients receiving isavuconazole;Rausch CR;Clin Infect Dis,2018

3. Breakthrough candidemia after the introduction of broad spectrum antifungal agents: a 5‐year retrospective study;Breda GL;Med Mycol,2018

4. The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies;Bergeron A;Blood,2012

5. Point‐of care diagnosis of invasive aspergillosis in non‐neutropenic patients: Aspergillus galactomannan lateral flow assay versus Aspergillus‐specific lateral flow device test in bronchoalveolar lavage;Jenks JD;Mycoses,2019

Cited by 128 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Limitations of antifungal prophylaxis in preventing invasive Candida surgical site infections after liver transplant surgery;Antimicrobial Agents and Chemotherapy;2024-02

2. Acute Invasive Pulmonary Aspergillosis: Clinical Presentation and Treatment;Seminars in Respiratory and Critical Care Medicine;2024-01-11

3. High-Risk Neutropenic Fever and Invasive Fungal Diseases in Patients with Hematological Malignancies;Microorganisms;2024-01-06

4. How Do I Manage Refractory Invasive Pulmonary Aspergillosis;Clinical Microbiology and Infection;2024-01

5. The outcome and the risk factors of mucormycosis among patients with hematological diseases: a systematic and meta-analysis;Frontiers in Medicine;2023-11-30